Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS · Delayed Price · Currency is USD
1.890
+0.002 (0.11%)
Nov 7, 2025, 3:48 PM EST
Medexus Pharmaceuticals Market Cap
Medexus Pharmaceuticals has a market cap or net worth of $61.75 million as of November 7, 2025. Its market cap has increased by 33.92% in one year.
Market Cap
61.75M
Enterprise Value
73.93M
Revenue
105.66M
Ranking
n/a
PE Ratio
76.62
Stock Price
$1.89
Market Cap Chart
Since December 27, 2013, Medexus Pharmaceuticals's market cap has increased from 30.10M to 61.75M, an increase of 105.13%. That is a compound annual growth rate of 6.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 61.75M | 3.96% |
| Dec 31, 2024 | 59.40M | 29.86% |
| Dec 29, 2023 | 45.74M | 48.80% |
| Dec 30, 2022 | 30.74M | -23.08% |
| Dec 31, 2021 | 39.97M | -48.56% |
| Dec 31, 2020 | 77.70M | 82.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.15M |
| Elite Pharmaceuticals | 645.15M |
| Glass House Brands | 580.08M |
| Northwest Biotherapeutics | 360.12M |
| American Oncology Network | 326.52M |
| CytoDyn | 314.94M |
| Nika Pharmaceuticals | 311.89M |
| Silence Therapeutics | 304.66M |